Shares of protein discovery platform Absci pop in market debut

Absci focuses on speeding drug development in the preclinical stages. The company has developed and acquired a handful of tools that can predict drug candidates, identify potential therapeutic targets and test therapeutic proteins on billions of cells and …

Read more @

Back to top button